We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAN
2301
DELISTED
The Aaron's Company Inc
AAN
| $107K | ﹤0.01% |
11,000
-8,200
| -43% | -$109K |
|
2302
Assembly Biosciences
ASMB
$507M
| $106K | ﹤0.01% |
5,400
-2,658
| -33% | -$64.3K |
|
2303
Airgain
AIRG
$71.9M
| $105K | ﹤0.01% |
14,575
-9,300
| -39% | -$74.2K |
|
2304
American Coastal Insurance
ACIC
$526M
| $104K | ﹤0.01% |
162,600
+3,800
| +2% | +$4.04K |
|
|
PVLA
2305
Palvella Therapeutics
PVLA
$2.05B
| $104K | ﹤0.01% |
1,134
-722
| -39% | -$93.1K |
|
2306
Cerus
CERS
$585M
| $103K | ﹤0.01% |
28,700
-422,400
| -94% | -$2.02M |
|
|
FCRD
2307
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $101K | ﹤0.01% |
35,268
-10,400
| -23% | -$34.2K |
|
2308
Lands' End
LE
$389M
| $100K | ﹤0.01% |
+12,900
| New | +$159K |
|
|
FSP
2309
Franklin Street Properties
FSP
$50.1M
| $98K | ﹤0.01% |
37,200
-119,300
| -76% | -$393K |
|
2310
LegalZoom.com
LZ
$1.39B
| $97K | ﹤0.01% |
11,300
-11,300
| -50% | -$117K |
|
|
BBBY
2311
DELISTED
Bed Bath & Beyond Inc
BBBY
| $97K | ﹤0.01% |
15,932
-552,168
| -97% | -$4.5M |
|
2312
Interface
TILE
$2B
| $96K | ﹤0.01% |
10,700
-3,400
| -24% | -$41.2K |
|
2313
Mustang Bio
MBIO
$4.78M
| $95K | ﹤0.01% |
270
-200
| -43% | -$92.7K |
|
|
TEAD
2314
Teads Holding Co
TEAD
$78.6M
| $95K | ﹤0.01% |
+26,000
| New | +$126K |
|
2315
Lipocine
LPCN
$17.6M
| $94K | ﹤0.01% |
12,329
-5,883
| -32% | -$65.7K |
|
|
ONCR
2316
DELISTED
Oncorus, Inc.
ONCR
| $92K | ﹤0.01% |
108,100
-42,600
| -28% | -$54.6K |
|
|
BNFT
2317
DELISTED
Benefitfocus, Inc.
BNFT
| $92K | ﹤0.01% |
14,500
-53,900
| -79% | -$400K |
|
|
ITI
2318
DELISTED
Iteris, Inc.
ITI
| $91K | ﹤0.01% |
30,700
-38,800
| -56% | -$116K |
|
2319
AGNC Investment
AGNC
$12.9B
| $90K | ﹤0.01% |
+10,700
| New | +$126K |
|
2320
XWELL
XWEL
$8.87M
| $90K | ﹤0.01% |
5,860
-12,695
| -68% | -$225K |
|
|
TESS
2321
DELISTED
Tessco Technologies Inc
TESS
| $90K | ﹤0.01% |
21,700
-11,800
| -35% | -$61.2K |
|
|
KLRS
2322
Kalaris Therapeutics
KLRS
$79.5M
| $89K | ﹤0.01% |
491
-1,187
| -71% | -$185K |
|
|
AKTS
2323
DELISTED
Akoustis Technologies Inc
AKTS
| $89K | ﹤0.01% |
29,900
-40,500
| -58% | -$164K |
|
|
DS
2324
DELISTED
Drive Shack Inc.
DS
| $89K | ﹤0.01% |
144,200
-23,400
| -14% | -$28K |
|
2325
Atossa Therapeutics
ATOS
$24.1M
| $88K | ﹤0.01% |
7,027
-1,460
| -17% | -$21.2K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.